Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-02-14 11:47 am Purchase | 13G | FREELINE THERAPEUTICS HLDGS FRLN | EVENTIDE ASSET MANAGEMENT LLC | 3,485,656 9.7% | 1,000,000 (+40.23%) | View |
| 2022-02-14 11:46 am Purchase | 13G | ESSA PHARMA INC EPIX | EVENTIDE ASSET MANAGEMENT LLC | 3,318,647 7.5% | 983,479 (+42.12%) | View |
| 2022-02-14 11:43 am Sale | 13G | ENTASIS THERAPEUTICS HLDGS INC ETTX | EVENTIDE ASSET MANAGEMENT LLC | 590,602 1.2% | -288,939 (-32.85%) | View |
| 2022-02-14 11:41 am Purchase | 13G | ZYMEWORKS INC ZYME | EVENTIDE ASSET MANAGEMENT LLC | 2,819,135 6.1% | 2,819,135 (New Position) | View |
| 2022-02-14 11:39 am Purchase | 13G | ANNEXON INC ANNX | EVENTIDE ASSET MANAGEMENT LLC | 2,850,000 7.4% | 845,384 (+42.17%) | View |
| 2022-02-14 11:37 am Purchase | 13G | VECTIVBIO HLDG AG VECT | EVENTIDE ASSET MANAGEMENT LLC | 2,339,044 6.7% | 2,339,044 (New Position) | View |
| 2022-02-14 11:35 am Purchase | 13G | PROMETHEUS BIOSCIENCES INC RXDX | EVENTIDE ASSET MANAGEMENT LLC | 3,742,507 9.6% | 3,742,507 (New Position) | View |
| 2022-02-14 11:33 am Purchase | 13G | COGENT BIOSCIENCES INC COGT | EVENTIDE ASSET MANAGEMENT LLC | 3,514,909 8.8% | 3,514,909 (New Position) | View |
| 2022-02-10 4:18 pm Purchase | 13G | KNOWBE4 INC CLASS A KNBE | EVENTIDE ASSET MANAGEMENT LLC | 4,177,983 10.1% | 4,177,983 (New Position) | View |
| 2021-02-12 4:19 pm Purchase | 13G | ESSA PHARMA INC EPIX | EVENTIDE ASSET MANAGEMENT LLC | 2,335,168 7% | 324,999 (+16.17%) | View |
| 2021-02-12 4:16 pm Sale | 13G | ARYA SCIENCES ACQUISITION CORP ARYAU | EVENTIDE ASSET MANAGEMENT LLC | 0 0% | -800,000 (Position Closed) | View |
| 2021-02-12 4:15 pm Sale | 13G | MAGENTA THERAPEUTICS INC MGTA | EVENTIDE ASSET MANAGEMENT LLC | 1,000,000 2.1% | -2,393,894 (-70.54%) | View |
| 2021-02-12 4:13 pm Sale | 13G | STEMLINE THERAPEUTICS INC STML | EVENTIDE ASSET MANAGEMENT LLC | 0 0% | -4,160,608 (Position Closed) | View |
| 2021-02-12 4:13 pm Purchase | 13G | VITAL FARMS INC VITL | EVENTIDE ASSET MANAGEMENT LLC | 2,053,232 5.2% | 2,053,232 (New Position) | View |
| 2021-02-12 4:11 pm Purchase | 13G | PRAXIS PRECISION MEDICINES INC PRAX | EVENTIDE ASSET MANAGEMENT LLC | 3,513,081 9.2% | 3,513,081 (New Position) | View |
| 2021-02-12 4:11 pm Purchase | 13G | PLIANT THERAPEUTICS INC PLRX | EVENTIDE ASSET MANAGEMENT LLC | 2,838,125 8% | 2,838,125 (New Position) | View |
| 2021-02-12 4:10 pm Purchase | 13G | SUTRO BIOPHARMA INC STRO | EVENTIDE ASSET MANAGEMENT LLC | 2,370,975 5.3% | 1,126,080 (+90.46%) | View |
| 2021-02-12 4:08 pm Purchase | 13G | KALA PHARMACEUTICALS INC KALA | EVENTIDE ASSET MANAGEMENT LLC | 3,450,000 6.2% | 3,450,000 (New Position) | View |
| 2021-02-12 4:07 pm Sale | 13G | ZOGENIX INC ZGNX | EVENTIDE ASSET MANAGEMENT LLC | 0 0% | -2,841,300 (Position Closed) | View |
| 2021-02-12 4:07 pm Purchase | 13G | FREELINE THERAPEUTICS HLDGS FRLN | EVENTIDE ASSET MANAGEMENT LLC | 2,485,656 7.5% | 2,485,656 (New Position) | View |